Kanya Rajangam - 18 Jul 2022 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Chief Medical & Devt. Officer
Signature
/s/ Mike Rhee, attorney-in-fact
Issuer symbol
SNTI
Transactions as of
18 Jul 2022
Net transactions value
$0
Form type
4
Filing time
20 Jul 2022, 18:00:12 UTC
Previous filing
15 Jul 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Stock Option (Right to Buy) Award $0 +327,750 $0.000000 327,750 18 Jul 2022 Common Stock 327,750 $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vest on July 5, 2023 and the remainder vest in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting date.